Clinical trial
Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By…
NCT00433576 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00433576 |
|---|---|
| Title | Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery |
| Official title | Phase I Repeat-Dose Study of Resveratrol in Colorectal Cancer Patients: Tolerability, Target Tissue Levels and Pharmacodynamics |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Stage I Colon Cancer, Stage I Rectal Cancer, Stage II Colon Cancer, Stage II Rectal Cancer, Stage III Colon Cancer, Stage III Rectal Cancer |
| Intervention type | Drug, Other |
| Interventions | resveratrol, pharmacological study, laboratory biomarker analysis |
| Enrollment | 20 |
| Start date | Dec 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | Mar 1, 2009 |
| First posted | Feb 12, 2007 |
| Last update posted | Sep 15, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: